Loma Therapeutics

Exploring the African market 🌍 This week our COO Stephanie Holstein-Rønsbo and Business Developer Caroline de Blanck are in Nairobi, Kenya to explore the market potential in Kenya and Africa. We are looking forward to all our meetings with hospitals, organizations helping SME's and potential future partners 🚀 Thank you to the BioInnovation Institute and Denmark in Kenya for organizing the trip.

Being supported by the BioInnovation Institute through their Venture Lab program has had profound impact on our development and has accelerated our mission of developing best-in-class treatment for HPV-positive cancers. A warm recommendation to apply for the programmes and join the supportive network.

We are excited to announce that Lea Fendler has joined Loma Therapeutics as a Founder’s Associate Intern 📣 Lea is currently pursuing her Master’s in Impact Entrepreneurship and Innovation with a specialization in Healthcare Innovation at Nova School of Business and Economics. Lea’s academic journey, passion for impact-driven startups, and two years of experience in startups and consulting greatly fit our efforts in the upcoming fundraising initiatives and market analysis in emerging markets.   We are thrilled to have Lea on board and look forward to the fresh perspectives she will bring to our projects.

🌍 World Mental Health Day: Addressing the Psychological Impact of Head and Neck Cancers On World Mental Health Day, we shed light on the profound psychological challenges faced by individuals undergoing treatment for head and neck cancers (HNC). Key Insights:  ❌ Head and neck cancers, including HPV-related types, have a devastating psychological toll. A staggering 86% of patients experience depression, a higher rate compared to other cancer types.    ❌ The psychological impact of cancer often surpasses the physical challenges, affecting patients' quality of life and mental well-being. Our therapeutic cancer vaccine is tailored for HPV-related cancers and pre-cancers and aims to: ✅ Reduce Psychological Burden: By offering a less invasive treatment option, minimizing the severe psychological impacts associated with current treatments.    ✅ Improve Quality of Life: Enabling patients to cope better and maintain mental well-being during and after treatment.    ✅ Offer Hope: Providing new avenues for treatment and recovery that prioritize both physical and mental health. Join us in our mission to transform the landscape of cancer care, supporting mental and physical health for patients worldwide. #WorldMentalHealthDay #CancerResearch #HPVCancer #TherapeuticVaccine #HealthcareInnovation #FightCancer #MentalHealthMatters 

Meet Martin Wiinberg Bardenfleth, our new Scientist 🚀 Martin's experience in working with immunotherapies and tumor models has already proven instrumental in his work planning and conducting the experimental strategy for Loma. With his interest in biotech startups and experience working together with start-ups on pre-clinical drug evaluation, we are excited to welcome Martin to the Loma Therapeutics Team!

Loma Therapeutics was thrilled to participate in the Nordic Life Science Days this week! It was an incredible opportunity to connect with investors and collaborators in biotech and life sciences. A big thank you to everyone for all the great conversations we have had! Our team - Stephanie, Caroline and Lasse - were excited about the enthusiasm we encountered when we shared our therapy for HPV-related tumors! We already look forward to next year, and we also look forward to future collaborations that will help advance innovation in cancer treatment!

We are thrilled to share that Loma Therapeutics has been selected as one of the five companies joining the BioInnovation Institute's Venture House Program! This next step in the Venture House Program will provide us with the resources and support needed to advance our therapy further through CMC development, and attract further funding. We are immensely proud to be part of this program and congratulations to the four other companies: Visibuilt, Cymab, Aida Oncology, and BioHalo! Our mission is to make a meaningful impact on patients' lives by providing new, effective treatment options for HPV-positive cancers, and with the help of the BII’s ecosystem, we’re one step closer to realizing that goal. Thank you to everyone involved for this incredible opportunity! 

Will we see you at Nordic Life Science Days 2024? 🔬 From the Loma Therapeutics team, you can meet COO Stephanie Holstein-Rønsbo, CBO Lasse Nørregaard, and Business developer Caroline de Blanck during NLS days 18 and 19 of September.  Come by the Nordic Star Pitch stage on the 18th at 10:35 for an introduction to the core of Loma Therapeutics. We are looking forward to meeting potential partners, investors and others at the event. #Immunotherapy #cancertreatment #HPVcancer #startup #NLSdays

Celebrating 1 year at BioInnovation Institute! 🎉🎉    Today, we celebrate our graduation from the Venture Lab program at Bioinnovation Institute. We have spent this year building an amazing team, expanded our pre-clinical data package, and laid out a clear strategy for Loma.    This program has been a game-changer, providing us with invaluable mentorship, resources, and a supportive community of fellow startups.    A huge thanks to the incredible team at BII for their great energy, and to everyone who’s been a part of this journey.     Can’t wait for the next steps for Loma.    Stephanie Holstein-Rønsbo Ditte Boilesen Lasse Nørregaard Caroline de Blanck Martin Wiinberg Diego R. Sanne Brun Jensen Umar Adegoke 

This summer, we had the pleasure of having Olivia Rando travel all the way from MIT, USA, to join Loma Therapeutics for an internship ☀️ Using her training in both Biological Engineering and Finance, Olivia has been an immense help to Loma and has amongst other things helped with numerous assays for our HPV therapy; developed specialized data analysis for our assays; and conducted a market analysis of cervical dysplasia in high-income countries. The entire Loma team wishes you all the best in your studies and whatever exciting opportunities lie ahead 🚀     Lasse Nørregaard Caroline de Blanck Stephanie Holstein-Rønsbo Ditte Boilesen Martin Wiinberg Diego R.